Cegedim Toekomstige groei

Future criteriumcontroles 3/6

Cegedim zal naar verwachting groeien in winst en omzet met respectievelijk 49.8% en 5.2% per jaar. De winst per aandeel zal naar verwachting groeien met 50.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 7.4% zijn.

Belangrijke informatie

49.8%

Groei van de winst

50.4%

Groei van de winst per aandeel

Healthcare Services winstgroei	30.1%
Inkomstengroei	5.2%
Toekomstig rendement op eigen vermogen	7.4%
Dekking van analisten	Low
Laatst bijgewerkt	25 Oct 2024

Recente toekomstige groei-updates

Recent updates

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 06

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

Nov 23

Winst- en omzetgroeiprognoses

ENXTPA:CGM - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	722	27	34	117	3
12/31/2025	689	23	30	110	3
12/31/2024	653	18	36	102	3
6/30/2024	634	2	13	93	N/A
3/31/2024	625	-3	18	95	N/A
12/31/2023	616	-7	22	98	N/A
9/30/2023	602	1	26	104	N/A
6/30/2023	589	10	30	111	N/A
3/31/2023	572	12	20	99	N/A
12/31/2022	555	14	10	86	N/A
9/30/2022	548	14	-7	64	N/A
6/30/2022	541	15	-25	42	N/A
3/31/2022	533	21	3	69	N/A
12/31/2021	525	26	31	96	N/A
9/30/2021	518	24	36	106	N/A
6/30/2021	512	22	41	116	N/A
3/31/2021	504	16	39	113	N/A
12/31/2020	497	11	36	110	N/A
9/30/2020	496	10	28	98	N/A
6/30/2020	494	8	21	85	N/A
3/31/2020	499	5	-6	57	N/A
12/31/2019	504	3	-33	29	N/A
9/30/2019	495	-1	-8	54	N/A
6/30/2019	486	-5	18	80	N/A
3/31/2019	477	0	41	102	N/A
12/31/2018	468	4	65	124	N/A
9/30/2018	464	8	41	100	N/A
6/30/2018	461	12	18	77	N/A
3/31/2018	459	10	N/A	75	N/A
12/31/2017	457	7	N/A	73	N/A
9/30/2017	452	-13	N/A	82	N/A
6/30/2017	438	-17	N/A	78	N/A
3/31/2017	435	-12	N/A	76	N/A
12/31/2016	429	-29	N/A	59	N/A
9/30/2016	438	13	N/A	52	N/A
6/30/2016	435	9	N/A	55	N/A
3/31/2016	432	1	N/A	9	N/A
12/31/2015	426	19	N/A	40	N/A
9/30/2015	364	0	N/A	89	N/A
6/30/2015	380	-6	N/A	62	N/A
3/31/2015	399	-4	N/A	130	N/A
12/31/2014	412	-8	N/A	127	N/A
9/30/2014	161	-26	N/A	132	N/A
6/30/2014	266	-11	N/A	163	N/A
3/31/2014	377	-5	N/A	143	N/A
12/31/2013	488	-14	N/A	150	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei CGM ( 49.8% per jaar) ligt boven de spaarquote ( 1.4% ).

Winst versus markt: De winst van CGM ( 49.8% per jaar) zal naar verwachting sneller groeien dan de French markt ( 12.6% per jaar).

Hoge groeiwinsten: De winst van CGM zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van CGM ( 5.2% per jaar) zal naar verwachting langzamer groeien dan de markt French ( 5.6% per jaar).

Hoge groei-inkomsten: De omzet van CGM ( 5.2% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CGM zal naar verwachting over 3 jaar laag zijn ( 7.4 %).

Cegedim Toekomstige groei

Future criteriumcontroles 3/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates increase by 15%

Price target decreased by 7.4% to €16.70

Cegedim SA Provides Earnings Guidance for the Full Year 2024

Price target decreased by 7.9% to €19.37

Consensus EPS estimates fall by 18%

Cegedim Provides Revenue Guidance for the Full Year 2023

Recent updates

Consensus EPS estimates increase by 15%

Cegedim SA to Report Fiscal Year 2024 Results on Mar 27, 2025

There May Be Reason For Hope In Cegedim's (EPA:CGM) Disappointing Earnings

First half 2024 earnings released: EPS: €0.046 (vs €0.64 loss in 1H 2023)

Price target decreased by 7.4% to €16.70

Cegedim SA Provides Earnings Guidance for the Full Year 2024

Cegedim SA's (EPA:CGM) CEO Will Probably Struggle To See A Pay Rise This Year

Price target decreased by 7.9% to €19.37

New major risk - Financial position

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: EPS: €0.051 (vs €0.68 in 3Q 2022)

Getting In Cheap On Cegedim SA (EPA:CGM) Might Be Difficult

Consensus EPS estimates fall by 18%

Cegedim SA to Report First Half, 2024 Results on Sep 26, 2024

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

Cegedim Provides Revenue Guidance for the Full Year 2023

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

New minor risk - Earnings quality

Cegedim SA Provides Revenue Guidance for the Full Year 2023

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

Consensus EPS estimates increase by 16%

When Should You Buy Cegedim SA (EPA:CGM)?

Full year 2022 earnings: EPS exceeds analyst expectations

Price target increased by 7.1% to €21.40

Cegedim SA Provides Group Revenue Guidance for the Year 2023

Less than half of directors are independent

Cegedim SA to Report First Half, 2023 Results on Sep 20, 2023

Consensus forecasts updated

Cegedim SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Consensus forecasts updated

Cegedim Provides Revenue Guidance for 2022

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

First half 2022 earnings released: €0.40 loss per share (vs €0.47 profit in 1H 2021)

Cegedim SA (ENXTPA:CGM) acquired Merito, SAS.

Upcoming dividend of €0.50 per share

Price target decreased to €28.83

Less than half of directors are independent

Cegedim, Malakoff Humanis, Groupe VYV, PRO BTP in Talks for Acquisition of Equity Stake in Cegedim Santé

Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?

Investor sentiment improved over the past week

Cegedim SA Provides Revenue Guidance for the Year 2022

Cegedim SA to Report First Half, 2022 Results on Sep 20, 2022

Cegedim Provides Revenue Guidance for the Year 2021

First half 2021 earnings released: EPS €0.47 (vs €0.34 loss in 1H 2020)

Consensus forecasts updated

Is Cegedim SA (EPA:CGM) Trading At A 26% Discount?

Should You Think About Buying Cegedim SA (EPA:CGM) Now?

Consensus forecasts updated

Cegedim Provides Revenue Guidance for the Year 2021

Cegedim (EPA:CGM) Seems To Use Debt Quite Sensibly

Cegedim's (EPA:CGM) Shareholders Are Down 33% On Their Shares

Full year 2020 earnings released: EPS €0.78 (vs €0.20 in FY 2019)

Cegedim SA Provides Earnings Guidance for the Year 2021

Are Investors Undervaluing Cegedim SA (EPA:CGM) By 43%?

New 90-day low: €23.20

What Is Cegedim SA's (EPA:CGM) Share Price Doing?

Analysts update estimates

What Is The Ownership Structure Like For Cegedim SA (EPA:CGM)?

Cegedim SA (EPA:CGM) Delivered A Weaker ROE Than Its Industry

What Does Cegedim's (EPA:CGM) CEO Pay Reveal?

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Market bids up stock over the past week

New 90-day high: €27.50

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

New 90-day low: €22.30

Analysts lower EPS estimates to €0.88

Analysts lower EPS estimates to €1.21

New 90-day low: €23.50

New 90-day low - €26.40